BioCentury | Oct 12, 2015
Clinical News
Bamosiran: Phase II data
...and a baseline IOP of >=23 mmHg showed that once-daily 0.375%, 0.75%, 1.125% and 1.5% bamosiran...
...twice-daily 0.5% timolol in reducing IOP from baseline to day 28. The 1.125% dose of bamosiran...
...subsidiary of Zeltia S.A. (Madrid:ZEL, Madrid, Spain). Sylentis S.A. , Madrid, Spain Product: Bamosiran ( SYL040012...
...twice-daily 0.5% timolol in reducing IOP from baseline to day 28. The 1.125% dose of bamosiran...
...subsidiary of Zeltia S.A. (Madrid:ZEL, Madrid, Spain). Sylentis S.A. , Madrid, Spain Product: Bamosiran ( SYL040012...